Skip to main content
Mobile dropdown close
More coming soon
Verification: Explore these additional resources
1 - 10 of 21 Displaying Results
An Open Letter from TraceLink’s CEO on the DSCSA Saleable Returns Enforcement Discretion
Read the letter from TraceLink CEO Shabbir Dahod on the FDA announcement on DSCSA verification requirement for saleable returns.
Solving Saleable Returns: Critical Steps Toward Meeting the Deadline
In this webinar series, TraceLink experts will guide you through the maze of saleable returns and product verification:
Digital Information Sharing: Master Data and Verification
Easily share master data with your trading partners and enable DSCSA saleable returns verification with TraceLink's digital sharing platform.
Why Pharmacies and Hospitals Need to Think “Outside the Portal” for Serialization
What pharmacies are required to do to be ready for serialization and why they need to start developing a digital data strategy today.
How Should My Pharmacy Connect to a National System?
Learn what the EU FMD requirements on pharmacists are and how to go about connecting to your National System.
Preparing for DSCSA Saleable Returns Verification
Understand the impact of the upcoming DSCSA saleable returns verification requirement for both pharma companies and wholesale distributors.
Interoperability for DSCSA Saleable Returns Verification: Standards Will Enable Industry Success
The DSCSA introduces a challenge for wholesale distributors. See the importance of open standards and the consequences of proprietary solutions.
Saleable Returns Briefing: Who is Affected?
Get the latest on the DSCSA saleable returns verification requirements and deadlines in 12 minutes.
How the 2019 DSCSA Requirement Impacts Wholesaler Operations
See how the decisions you make about DSCSA compliance can minimize the effort, cost, and disruption of implementing saleable returns solutions.
Poll: Wholesalers’ DSCSA Verification Plans Lagging
With only 12 months left to prepare, a startling number of wholesalers have not assessed the potential impact of saleable returns on their operations.